Dupilumab Use in Moderate-to-Severe Atopic Dermatitis

Marcia L. Buck, PharmD, FCCP, FPPAG, BCPPS


Pediatr Pharm. 2019;25(6) 

In This Article

Drug Interactions

No drug interactions with dupilumab have been identified to date. Patients receiving dupilumab are considered immunosuppressed and should not receive live vaccines due to the risk for infection. Non-live (killed) vaccines may be administered and have been found to produce appropriate seroconversion rates.[2]